The different faces of shared autoimmunity

被引:20
作者
Rodríguez-Reyna, TS [1 ]
Alarcón-Segovia, D [1 ]
机构
[1] Inst Nacl Nutr Salvador Zubiran, Dept Immunol & Rheumatol, Mexico City 14000, DF, Mexico
关键词
overlap syndromes; shared autoimmunity; rhupus; sclerodermatomyositis; PDCD1;
D O I
10.1016/j.autrev.2005.09.005
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The concept of shared autoinummity comprises various forms of disease: rheumatic diseases in several members of the same family, the coincidence of autoimmune rheumatic with non-rheumatic diseases in relatives of patients, the presence of autoantibodies in healthy relatives of autoimmune disease patients, and the development of two or more autoimmune rheumatic diseases in one patient, the so-called overlap syndromes. The genetic and environmental factors that lead to these phenomena interact in a complex fashion and influence the distinct phenotypic characteristics of each patient. In a previous case series, we described 23 Mexican Mestizo patients with overlap syndromes. Interestingly, rhupus tends to develop sequentially while sclerodermatomyositis tends to appear simultaneously. The clinical course of the other overlap syndromes is rather aggressive, although clinical manifestations respond to standard treatment. The second and/or third disease appears while the first one is still active, even with adequate treatment. The distinct course of overlap syndromes may be partially explained by the interplay of environmental factors with genes that predispose to autoirrummity in general and to manifestations of specific diseases. The analyses of genes that will help understand the pathophysiology of these diseases include several MHC complex genes, cytokines, AIRE, and PDCD1 amongst others. (c) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:86 / 88
页数:3
相关论文
共 18 条
[1]   Familial aggregation of systemic lupus erythematosus, rheumatoid arthritis, and other autoimmune diseases in 1,177 lupus patients from the GLADEL cohort [J].
Alarcon-Segovia, D ;
Alarcón-Riquelme, ME ;
Cardiel, MH ;
Caeiro, F ;
Massardo, L ;
Villa, AR ;
Pons-Estel, BA .
ARTHRITIS AND RHEUMATISM, 2005, 52 (04) :1138-1147
[2]  
ALARCONSEGOVIA D, 1989, J RHEUMATOL, V16, P328
[3]  
Anaya JM, 2002, J RHEUMATOL, V29, P1874
[4]   CONCURRENCE OF SUBACUTE CUTANEOUS LUPUS-ERYTHEMATOSUS AND RHEUMATOID-ARTHRITIS [J].
COHEN, S ;
STASTNY, P ;
SONTHEIMER, RD .
ARTHRITIS AND RHEUMATISM, 1986, 29 (03) :421-425
[5]   Association of PDCD1 with susceptibility to systemic lupus erythematosus - Evidence of population-specific effects [J].
Ferreiros-Vidal, I ;
Gomez-Reino, JJ ;
Barros, F ;
Carracedo, A ;
Carreira, P ;
Gonzalez-Escribano, F ;
Liz, M ;
Martin, J ;
Ordi, J ;
Vicario, JL ;
Gonzalez, A .
ARTHRITIS AND RHEUMATISM, 2004, 50 (08) :2590-2597
[6]  
GUIZIOU C, 1987, REV RHUM, V54, P457
[7]   Gene map of the extended human MHC [J].
Roger Horton ;
Laurens Wilming ;
Vikki Rand ;
Ruth C. Lovering ;
Elspeth A. Bruford ;
Varsha K. Khodiyar ;
Michael J. Lush ;
Sue Povey ;
C. Conover Talbot ;
Mathew W. Wright ;
Hester M. Wain ;
John Trowsdale ;
Andreas Ziegler ;
Stephan Beck .
Nature Reviews Genetics, 2004, 5 (12) :889-899
[8]  
MEDSGER TA, 2001, ARTHRITIS ALLIED CON, P1590
[9]   The systemic lupus erythematosus-associated PDCD1 polymorphism PD1.3A in lupus nephritis [J].
Prokunina, L ;
Gunnarsson, I ;
Sturfelt, G ;
Truedsson, L ;
Seligman, VA ;
Olson, JL ;
Seldin, MF ;
Criswell, LA ;
Alarcón-Riquelme, ME .
ARTHRITIS AND RHEUMATISM, 2004, 50 (01) :327-328
[10]   Tumor necrosis factor-alpha-308 promoter polymorphism contributes independently to HLA alleles in the severity of rheumatoid arthritis in Mexicans [J].
Rodríguez-Carreón, AA ;
Zúñiga, J ;
Hernández-Pacheco, G ;
Rodríguez-Pérez, JM ;
Pérez-Hernández, N ;
de Oca, JVM ;
Cardiel, MH ;
Granados, J ;
Vargas-Alarcón, G .
JOURNAL OF AUTOIMMUNITY, 2005, 24 (01) :63-68